Difuran-substituted quinoxalines as a novel class of PI3Kα H1047R mutant inhibitors: Synthesis, biological evaluation and structure-activity relationship
Keywords: Proliferation; Anticancer drug; Phosphatidylinositol 3-kinase inhibitor; Apoptosis; Structure-activity relationship;